Carnegie Mellon University researchers unveiled AggreBots, microscopic living robots constructed from human lung cells with customizable motility enabled by a novel tissue engineering platform. Published in Science Advances, this innovation opens promising avenues for navigating complex biological environments to deliver therapeutics or perform mechanical interventions in vivo, marking a new frontier in biohybrid robotics.